ORBi: Amadori Sergio - Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia : final results of AML-13, a randomized phase-3 study

Reference : Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction ...


	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Hematology
	To cite this reference:	http://hdl.handle.net/2268/12369

Title :	Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia : final results of AML-13, a randomized phase-3 study
Language :	English
Author, co-author :	Amadori, Sergio [ > > ]
	Suciu, Stefan [ > > ]
	Jehn, Ulrich [ > > ]
	Stasi, Roberto [ > > ]
	Thomas, Xavier [ > > ]
	Marie, Jean-Pierre [ > > ]
	Muus, Petra [ > > ]
	Lefrère, François [ > > ]
	Berneman, Zwi [ > > ]
	Fillet, Georges [Université de Liège - ULg > Département des sciences cliniques > Hématologie - Oncologie médicale >]
	Denzlinger, Claudio [ > > ]
	Willemze, Roel [ > > ]
	Leoni, Pietro [ > > ]
	Leone, Giuseppe [ > > ]
	Casini, Marco [ > > ]
	Ricciuti, Francesco [ > > ]
	Vignetti, Marco [ > > ]
	Beeldens, Filip [ > > ]
	Mandelli, Franco [ > > ]
	de Witte, Theo [ > > ]
Publication date :	2005
Journal title :	Blood
Volume :	106
Pages :	27-34
Permalink :	http://hdl.handle.net/2268/12369

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Open access	214.pdf		Publisher postprint	277.39 kB	View/Open

All documents in ORBi are protected by a user license.